TABLE OF CONTENTS
1 INTRODUCTION 25
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.3 OVERVIEW OF THE NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET 25
1.4 LIMITATIONS 26
1.5 MARKETS COVERED 27
2 MARKET SEGMENTATION 29
2.1 MARKETS COVERED 29
2.2 GEOGRAPHICAL SCOPE 30
2.3 YEARS CONSIDERED FOR THE STUDY 31
2.4 CURRENCY AND PRICING 31
2.5 DBMR TRIPOD DATA VALIDATION MODEL 32
2.6 MULTIVARIATE MODELLING 35
2.7 TYPE LIFELINE CURVE 35
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 36
2.9 DBMR MARKET POSITION GRID 37
2.10 MARKET END USER COVERAGE GRID 38
2.11 VENDOR SHARE ANALYSIS 39
2.12 SECONDARY SOURCES 40
2.13 ASSUMPTIONS 40
3 EXECUTIVE SUMMARY 41
4 PREMIUM INSIGHTS 44
4.1 PESTEL ANALYSIS 45
4.2 PORTERS FIVE FORCES MODEL 46
4.3 STRATEGIC INITIATIVES 47
5 NORTH AMERICA DIALYZER PROCESSING MACHINES MARKET, REGULATIONS 48
5.1 REGULATORY SCENARIO IN THE U.S 48
6 MARKET OVERVIEW 49
6.1 DRIVERS 51
6.1.1 INCREASING PREVALENCE OF END-STAGE RENAL DISEASE (ESRD) 51
6.1.2 RISING DEMAND FOR HOME-BASED DIALYSIS PROCEDURES 51
6.1.3 COST-EFFECTIVENESS AND EFFICIENCY 52
6.2 RESTRAINTS 53
6.2.1 STRINGENT REGULATIONS FOR APPROVAL 53
6.2.2 POSSIBLE RISK OF INFECTIONS 53
6.3 OPPORTUNITIES 54
6.3.1 RISE IN TECHNOLOGICAL ADVANCEMENTS 54
6.3.2 INCREASING FOCUS ON INFECTION CONTROL 55
6.4 CHALLENGES 55
6.4.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS TO OPERATE DIALYZER REPROCESSING MACHINES 55
6.4.2 LACK OF STANDARDIZATION 56
7 NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET, BY TYPE 57
7.1 OVERVIEW 58
7.2 SEMI-AUTOMATIC 61
7.3 AUTOMATIC 62
8 NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET, BY MODALITY 63
8.1 OVERVIEW 64
8.2 BENCHTOP 67
8.2.1 SEMI-AUTOMATIC 68
8.2.2 AUTOMATIC 68
8.3 STANDALONE 68
8.3.1 SEMI-AUTOMATIC 69
8.3.2 AUTOMATIC 69
9 NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET, BY STATION TYPE 70
9.1 OVERVIEW 71
9.2 DUAL STATION 74
9.3 SINGLE STATION 75
10 NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET, BY END USER 76
10.1 OVERVIEW 77
10.2 DIALYSIS CENTERS 80
10.3 HOSPITAL 81
10.4 HOME USE 82
11 NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET, BY REGION 83
11.1 NORTH AMERICA 84
11.1.1 U.S. 91
11.1.2 CANADA 93
11.1.3 MEXICO 95
12 NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET: COMPANY LANDSCAPE 97
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 97
13 SWOT ANALYSIS 98
14 NORTH AMERICA DIALYZER REPROCESSING MACHINES MARKET 99
14.1 MEDIVATORS INC. (SUBSIDIARY OF STERIS) 99
14.1.1 COMPANY SNAPSHOT 99
14.1.2 REVENUE ANALYSIS 99
14.1.3 COMPANY SHARE ANALYSIS 100
14.1.4 PRODUCT PORTFOLIO 100
14.1.5 RECENT DEVELOPMENTS 100
14.2 HEMANT SURGICAL INDUSTRIES LTD. 101
14.2.1 COMPANY SNAPSHOT 101
14.2.2 REVENUE ANALYSIS 101
14.2.3 COMPANY SHARE ANALYSIS 102
14.2.4 PRODUCT PORTFOLIO 102
14.2.5 RECENT DEVELOPMENTS 102
14.3 SAUBERN 103
14.3.1 COMPANY SNAPSHOT 103
14.3.2 COMPANY SHARE ANALYSIS 103
14.3.3 PRODUCT PORTFOLIO 104
14.3.4 RECENT DEVELOPMENTS 104
14.4 P.K. SCIENTIFIC & CHEMICALS 105
14.4.1 COMPANY SNAPSHOT 105
14.4.2 PRODUCT PORTFOLIO 105
14.4.3 RECENT DEVELOPMENT 105
14.5 LABSMED. 106
14.5.1 COMPANY SNAPSHOT 106
14.5.2 COMPANY SHARE ANALYSIS 106
14.5.3 PRODUCT PORTFOLIO 107
14.5.4 RECENT DEVELOPMENTS 107
14.6 ATLANTIC BIOMEDICAL 108
14.6.1 COMPANY SNAPSHOT 108
14.6.2 COMAPYN SHARE ANALYSIS 108
14.6.3 PRODUCT PORTFOLIO 109
14.6.4 RECENT DEVELOPMENT 109
14.7 ADVIN HEALTH CARE 110
14.7.1 COMPANY SNAPSHOT 110
14.7.2 PRODUCT PORTFOLIO 110
14.7.3 RECENT DEVELOPMENTS 110
14.8 ANJUE MEDICAL EQUIPMENT CO., LTD. 111
14.8.1 COMPANY SNAPSHOT 111
14.8.2 PRODUCT PORTFOLIO 111
14.8.3 RECENT DEVELOPMENT 111
14.9 CLINIVA HEALTHCARE 112
14.9.1 COMPANY SNAPSHOT 112
14.9.2 PRODUCT PORTFOLIO 112
14.9.3 RECENT DEVELOPMENT 112
14.10 GERYFALCON HEALTHCARE PVT. LTD. 113
14.10.1 COMPANY SNAPSHOT 113
14.10.2 PRODUCT PORTFOLIO 113
14.10.3 RECENT DEVELOPMENT 113
14.11 NANOTECH 114
14.11.1 COMPANY SNAPSHOT 114
14.11.2 PRODUCT PORTFOLIO 114
14.11.3 RECENT DEVELOPMENTS 114
14.12 WESLEY BIOTECH 115
14.12.1 COMPANY SNAPSHOT 115
14.12.2 PRODUCT PORTFOLIO 115
14.12.3 RECENT DEVELOPMENT 115
15 QUESTIONNAIRE 116
16 RELATED REPORTS 119

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.